Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion

Blood (2017) 130 (5): 677–685.

https://doi.org/10.1182/blood-2017-04-779769

Published: 2017

Includes: Supplemental data

Journal Articles

Children with Acute Leukemia Given Hematopoietic Stem Cell Transplantation (HSCT) from an HLA-Compatible Sibling, or an Unrelated Donor (UD) or an HLA-Haploidentical Relative after Alpha/Beta T-Cell Depletion Have a Comparable Outcome

Alice Bertaina, MDPhD, Barbarella Lucarelli, MD, Riccardo Masetti, MD, Pietro Merli, MD, Roberto Rondelli, MD, Giuseppina Li Pira, PhD, Marco Andreani, PhD, Lavinia Grapulin, MD, Daniela Pende, MD, Michela Falco, PhD, Maria Rita Pinto, MD, Valentina Bertaina, PhD, Maria Teresa Romano, MD, Stefano Ceccarelli, MD, Letizia Pomponia Brescia, MD, Daria Pagliara, MD, Alessandro Moretta, MD, Lorenzo Moretta, MD, Franco Locatelli, Prof, MD PhD

Blood (2015) 126 (23): 195.

https://doi.org/10.1182/blood.V126.23.195.195

Published: 2015

Journal Articles

Clinical and Biological Characterization of Children with FLT3ITD Mutated Acute Myeloid Leukemia (AML): A Report from the AIEOP AML-2002 Study Group

Elena Manara, PhD, Valeria Bisio, BS, Marco Frison, MD, Katia Polato, Claudia Tregnago, PhD, Barbara Buldini, MD, Riccardo Masetti, MD, Roberto Rondelli, MD, Gianni Cazzaniga, PhD, Andrea Biondi, Prof, MD, Franco Locatelli, Prof, MD PhD, Martina Pigazzi, PhD, Giuseppe Basso, Prof, MD

Blood (2015) 126 (23): 3845.

https://doi.org/10.1182/blood.V126.23.3845.3845

Published: 2015

Journal Articles

Core Binding Factor Acute Myeloid Leukemia In Pediatric Patients Of The AIEOP AML 2002/01 Trial: Screening and Prognostic Impact Of cKIT Mutations

Elena Manara, PhD, Valeria Bisio, BS, Valzerda Beqiri, MD, Roberto Rondelli, Giuseppe Menna, Concetta Micalizzi, Nicola Santoro, Franco Locatelli, Giuseppe Basso, MD, Martina Pigazzi, PhD

Blood (2013) 122 (21): 2655.

https://doi.org/10.1182/blood.V122.21.2655.2655

Published: 2013

Journal Articles

Core Binding Factor Acute Myeloid Leukemia In Pediatric Patients Enrolled In The AIEOP AML 2002/01 Trial: The Impact Of Minimal Residual Disease On Patient Outcome

Martina Pigazzi, Ph.D., Valzerda Beqiri, MD, Elena Manara, PhD, Roberto Rondelli, Riccardo Masetti, MD, Carmelo Rizzari, MD, PhD, Maria Caterina Putti, Andrea Pession, Franco Locatelli, Giuseppe Basso, MD

Blood (2013) 122 (21): 3884.

https://doi.org/10.1182/blood.V122.21.3884.3884

Published: 2013

Journal Articles

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia

Andrea Pession, Riccardo Masetti, Carmelo Rizzari, Maria Caterina Putti, Fiorina Casale, Franca Fagioli, Matteo Luciani, Luca Lo Nigro, Giuseppe Menna, Concetta Micalizzi, Nicola Santoro, Anna Maria Testi, Marco Zecca, Andrea Biondi, Martina Pigazzi, Sergio Rutella, Roberto Rondelli, Giuseppe Basso, Franco Locatelli

Blood (2013) 122 (2): 170–178.

https://doi.org/10.1182/blood-2013-03-491621

Published: 2013

Journal Articles

Favourable Outcome in Infants with Acute Myeloid Leukemia Treated with the AIEOP AML 2002/01 Protocol

Riccardo Masetti, MD, Martina Pigazzi, PhD, Andrea Pession, Prof, MD, Carmelo Rizzari, MD, PhD, Nicola Santoro, Luca lo Nigro, Matteo Luciani, Giuseppe Menna, Roberto Rondelli, Giuseppe Basso, Franco Locatelli

Blood (2012) 120 (21): 3585.

https://doi.org/10.1182/blood.V120.21.3585.3585

Published: 2012

Journal Articles

Presence of high- ERG expression is an independent unfavorable prognostic marker in MLL -rearranged childhood myeloid leukemia

Martina Pigazzi, Riccardo Masetti, Francesco Martinolli, Elena Manara, Alessandra Beghin, Roberto Rondelli, Franco Locatelli, Franca Fagioli, Andrea Pession, Giuseppe Basso

Blood (2012) 119 (4): 1086–1087.

https://doi.org/10.1182/blood-2011-10-385815

Published: 2012

Journal Articles

Results of the AIEOP AML 2002/01 Study for Treatment of Children with Acute Myeloid Leukemia.

Andrea Pession, C. Rizzari, Maria Caterina Putti, Riccardo Masetti, Fiorina Casale, Franca Fagioli, Luca Lo Nigro, Matteo Luciani, Concetta Micalizzi, Giuseppe Menna, Nicola Santoro, Anna Maria Testi, Roberto Rondelli, Andrea Biondi, Giuseppe Basso, Franco Locatelli

Blood (2009) 114 (22): 17.

https://doi.org/10.1182/blood.V114.22.17.17

Published: 2009

Journal Articles

Prevalence and Prognostic Impact of CEBPA mutations in Children with AML Treated with the AIEOP-LAM 2002/01 Protocol.

Giovanni Cazzaniga, Riccardo Masetti, Giulia Ferrari, Tiziana Coliva, Carmelo Rizzari, Roberto Rondelli, Fiorina Casale, Franca Fagioli, Luca Lo Nigro, Matteo Luciani, Concetta Micalizzi, Giuseppe Menna, Maria Caterina Putti, Nicola Santoro, Giuseppe Basso, Franco Locatelli, Andrea Biondi, Andrea Pession

Blood (2009) 114 (22): 2643.

https://doi.org/10.1182/blood.V114.22.2643.2643

Published: 2009

Journal Articles

High Dose Therapy (HDCT) and Autologous Haematopoietic Stem Cell Transplantation (aSCT) in Paediatric Patients with Recurrent or Refractory Hodgkin’s Disease (HD): Results and Outcome.

Arcangelo Prete, MD, Federico Bonetti, MD, Roberto Rondelli, MD, Simone Cesaro, MD, Sandro Dallorso, MD, Claudio Favre, MD, Franca Fagioli, MD, Chiara Messina, MD, Roberta Burnelli, MD, Franco Locatelli, MD, Andrea Pession, MD

Blood (2005) 106 (11): 2088.

https://doi.org/10.1182/blood.V106.11.2088.2088

Published: 2005

Journal Articles

Intravenous (i.v.) or Oral (os) Busulphan (BUS) in Children Prior to Autologous (Auto) or Allogeneic (Allo) Stem Cell Transplantation (SCT): Pharmacokinetics (PK), Toxicity and Compliance.

Arcangelo Prete, MD, Antonella Bartoli, MD, Claudia Castellini, MD, Roberto Rondelli, MD, Riccardo Masetti, MD, Andrea Pession, MD, Mario Regazzi-Bonora, MD

Blood (2005) 106 (11): 5320.

https://doi.org/10.1182/blood.V106.11.5320.5320

Published: 2005

Journal Articles

Children with TEL/AML1-Positive Acute Lymphoblastic Leukemia (ALL) and Favorable Presenting Features May Benefit from the Use of Vincristine-Dexamethasone (VCR-DXM) Pulses on Top of Antimetabolite-Based Continuation Therapy.

Blood (2005) 106 (11): 9.

https://doi.org/10.1182/blood.V106.11.9.9

Published: 2005

Journal Articles

Acute Lymphoblastic Leukemia in Children with Associated Genetic Conditions Other Than Down Syndrome. The AIEOP Experience.

Ottavio Ziino, Roberto Rondelli, Fulvio Porta, Rossella Mura, Concetta Micalizzi, Valentino Conter, Marie France Pinta Boccalatte, Chiara Messina, Matteo Luciani, Elena Barisone, Franco Locatelli, Andrea Pession, Giuseppe Basso, Andrea Biondi, Giuseppe Masera, Maurizio Aricò

Blood (2005) 106 (11): 863.

https://doi.org/10.1182/blood.V106.11.863.863

Published: 2005

Journal Articles

High Dose Methotrexate (HD MTX at 2 gr/sqm x 4) Associated to Extended Intrathecal (IT) Chemotherapy Is Effective for Prevention of Central Nervous System (CNS) Relapse in Childhood ALL Treated with BFM Systemic Therapy.

Blood (2005) 106 (11): 10.

https://doi.org/10.1182/blood.V106.11.10.10

Published: 2005

Journal Articles

Outcome of Children with All Given HSCT from Unrelated Volunteers Has Significantly Improved over Time and Now Is Comparable to That of Children Transplanted from an HLA-Identical Sibling.

Franco Locatelli, MD, Marco Zecca, MD, Andrea Pession, MD, Cornelio Uderzo, MD, Giorgio Dini, MD, Franca Fagioli, MD, Claudio Favre, MD, Valentino Conter, MD, Roberto Rondelli, MD, Federico Bonetti, MD, Chiara Messina, MD

Blood (2004) 104 (11): 2156.

https://doi.org/10.1182/blood.V104.11.2156.2156

Published: 2004

Journal Articles

Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome

Marco Zecca, Arcangelo Prete, Roberto Rondelli, Edoardo Lanino, Adriana Balduzzi, Chiara Messina, Franca Fagioli, Fulvio Porta, Claudio Favre, Andrea Pession, Franco Locatelli

Blood (2002) 100 (4): 1192–1200.

https://doi.org/10.1182/blood-2001-11-0059

Published: 2002

Journal Articles

Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy

Roberto M. Lemoli, Giovanni Martinelli, Elena Zamagni, Maria Rosa Motta, Simonetta Rizzi, Carolina Terragna, Roberto Rondelli, Sonia Ronconi, Antonio Curti, Francesca Bonifazi, Sante Tura, Michele Cavo

Blood (2000) 95 (7): 2234–2239.

https://doi.org/10.1182/blood.V95.7.2234

Published: 2000

Journal Articles

Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial

Franco Locatelli, Marco Zecca, Roberto Rondelli, Federico Bonetti, Giorgio Dini, Arcangelo Prete, Chiara Messina, Cornelio Uderzo, Mimmo Ripaldi, Fulvio Porta, Giovanna Giorgiani, Eugenia Giraldi, Andrea Pession

Blood (2000) 95 (5): 1572–1579.

https://doi.org/10.1182/blood.V95.5.1572.005k12_1572_1579

Published: 2000

Journal Articles

Expression of Myeloid Markers Lacks Prognostic Impact in Children Treated for Acute Lymphoblastic Leukemia: Italian Experience in AIEOP-ALL 88-91 Studies

Maria Caterina Putti, Roberto Rondelli, Maria Grazia Cocito, Maurizio Aricó, Laura Sainati, Valentino Conter, Cesare Guglielmi, Angelo Cantú-Rajnoldi, Rita Consolini, Andrea Pession, Luigi Zanesco, Giuseppe Masera, Andrea Biondi, Giuseppe Basso

Blood (1998) 92 (3): 795–801.

https://doi.org/10.1182/blood.V92.3.795

Published: 1998

NARROW

Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion

Children with Acute Leukemia Given Hematopoietic Stem Cell Transplantation (HSCT) from an HLA-Compatible Sibling, or an Unrelated Donor (UD) or an HLA-Haploidentical Relative after Alpha/Beta T-Cell Depletion Have a Comparable Outcome

Clinical and Biological Characterization of Children with FLT3ITD Mutated Acute Myeloid Leukemia (AML): A Report from the AIEOP AML-2002 Study Group

Core Binding Factor Acute Myeloid Leukemia In Pediatric Patients Of The AIEOP AML 2002/01 Trial: Screening and Prognostic Impact Of cKIT Mutations

Core Binding Factor Acute Myeloid Leukemia In Pediatric Patients Enrolled In The AIEOP AML 2002/01 Trial: The Impact Of Minimal Residual Disease On Patient Outcome

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia

Favourable Outcome in Infants with Acute Myeloid Leukemia Treated with the AIEOP AML 2002/01 Protocol

Presence of high- ERG expression is an independent unfavorable prognostic marker in MLL -rearranged childhood myeloid leukemia

Results of the AIEOP AML 2002/01 Study for Treatment of Children with Acute Myeloid Leukemia.

Prevalence and Prognostic Impact of CEBPA mutations in Children with AML Treated with the AIEOP-LAM 2002/01 Protocol.

High Dose Therapy (HDCT) and Autologous Haematopoietic Stem Cell Transplantation (aSCT) in Paediatric Patients with Recurrent or Refractory Hodgkin’s Disease (HD): Results and Outcome.

Intravenous (i.v.) or Oral (os) Busulphan (BUS) in Children Prior to Autologous (Auto) or Allogeneic (Allo) Stem Cell Transplantation (SCT): Pharmacokinetics (PK), Toxicity and Compliance.

Children with TEL/AML1-Positive Acute Lymphoblastic Leukemia (ALL) and Favorable Presenting Features May Benefit from the Use of Vincristine-Dexamethasone (VCR-DXM) Pulses on Top of Antimetabolite-Based Continuation Therapy.

Acute Lymphoblastic Leukemia in Children with Associated Genetic Conditions Other Than Down Syndrome. The AIEOP Experience.

High Dose Methotrexate (HD MTX at 2 gr/sqm x 4) Associated to Extended Intrathecal (IT) Chemotherapy Is Effective for Prevention of Central Nervous System (CNS) Relapse in Childhood ALL Treated with BFM Systemic Therapy.

Outcome of Children with All Given HSCT from Unrelated Volunteers Has Significantly Improved over Time and Now Is Comparable to That of Children Transplanted from an HLA-Identical Sibling.

Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome

Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy

Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial

Expression of Myeloid Markers Lacks Prognostic Impact in Children Treated for Acute Lymphoblastic Leukemia: Italian Experience in AIEOP-ALL 88-91 Studies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only